Abstract. TMEM16A is a major component of Ca 2+ -activated Cl − channel (CaCC) conductance in murine portal vein smooth muscle cells (mPVSMCs). Here, the regulation of CaCC activity by the actin cytoskeleton was examined in mPVSMCs. Actin disruption by cytochalasin D did not affect the current density, but increased the deactivation time constant in mPVSMCs. The elongated deactivation was recovered by jasplakinolide. When murine TMEM16A was transfected into HEK293 cells that have a poorly developed actin cytoskeleton, electrophysiological properties of CaCC currents were not changed by cytochalasin D. In conclusion, the CaCC activity in mPVSMCs is modified by the interaction of TMEM16A with abundant actin cytoskeleton.
Short Communication
The Ca 2+ -activated Cl − channel (CaCC) plays substantial roles in physiological functions including fluid secretion, neuronal excitation, and smooth muscle contraction. In vascular smooth muscles (VSMs), CaCC is involved in the regulation of membrane excitability and muscle tone. Recently, TMEM16A has been identified as a molecular component responsible for CaCC in various tissues (1 -3) . TMEM16A is functionally expressed also in several VSMs including portal vein (4) .
The activity of ion channels is frequently modulated by direct interaction or/and functional coupling with intracellular proteins including the auxiliary subunits, cytoskeletons, scaffold proteins, and organelles. Among these regulatory proteins, cytoskeleton such as actin filament is known to interact with various types of membrane proteins and modify the physiological functions. Despite the physiological significances of CaCC encoded by TMEM16A gene in VSMs, the modulation of its activity by regulatory proteins remains to be identified. The present study was undertaken to clarify the contribution of the actin cytoskeleton to CaCC activity in murine portal vein VSM cells (mPVSMCs) by using electrophysiological analysis.
All experiments were approved by the Ethics Committee of Nagoya City University and were conducted in accordance with the Guiding Principles for the Care and Use of Laboratory Animals of The Japanese Pharmacological Society. Freshly isolated mPVSMCs were prepared as described previously (4) . Electrophysiological studies were performed using a whole cell voltageclamp technique with an EPC-7 amplifier (HEKA Electronics, Darmstadt, Germany), an analog-digital converter (Digidata 1440A; Axon Instruments, Foster City, CA, USA), and pCLAMP software (version 8.2; Axon Instruments). Pooled data are shown as means ± S.E.M. Statistical significance between two or among groups was determined by Student's t-test or Tukey-Kramer's test after one-way ANOVA, respectively. P-values < 0.05 were considered statistically significant.
Single mPVSMCs were depolarized from a holding potential of −60 to +60 mV for 1 s under whole-cell voltage clamp. Using the pipette solution, which contained 120 mM CsCl, 20 mM tetraethylammonium (TEA)-Cl, and 1 mM Ca 2+ , the outward currents with slow activation and characteristic inward tail currents were observed (Fig. 1A) . These currents were largely blocked by CaCC inhibitors, 100 mM niflumic acid (Sigma-Aldrich, St. Louis, MO, USA) or 10 mM T16A inh -A01 (Tocris Bioscience, Bristol, UK), as reported previously (4) . Cytochalasin D (Invitrogen, Carlsbad, CA, USA) was added to inhibit actin polymerization in mPVSMCs. It was confirmed that actin cytoskeleton in VSMCs was mostly disrupted by treatment with 1 mM cytochalasin D for 4 h (5). The treatment with cytochalasin D did not alter the cell capacitance (24.9 ± 1.6 pF, n = 14, P > 0.05 vs. vehicle control of 20.3 ± 1.5 pF, n = 8) or the peak amplitude of outward current density (6.6 ± 0.8 pA/pF at +60 mV, n = 14, P > 0.05 vs. vehicle control of 4.7 ± 0.6 pA/pF, n = 8; Fig. 1B ) in mPVSMCs. The current reversed at near 0 mV, which is the theoretical equilibrium potential of Cl − (E Cl = −0.9 mV) in the present experimental condition, regardless of treatment with cytochalasin D. There was no significant difference in the time constant of activation (t act ) at +60 mV between the vehicle control (278 ± 47 ms, n = 8) and cytochalasin D (257 ± 23 ms, n = 14, P > 0.05) groups ( Fig. 1: C and E). On the other hand, the treatment with cytochalasin D significantly elongated the time constant of deactivation (t deact ) at +60 mV, which was detected as the tail current at −60 mV (85.3 ± 5.9 ms, n = 14) from that of the vehicle control (55.3 ± 5.9 ms, n = 8, P < 0.05; In VSMCs, the resting membrane potential is approximately −60 mV, and the equilibrium potential of Cl − is estimated to be approximately −30 mV (6) , suggesting that an increase in Cl − conductance elicits membrane depolarization at the resting potential. Therefore, the elongated deactivation of CaCC is likely to increase the membrane excitability during after-hyperpolarization phases of an action potential and facilitate membrane depolarization to elicit the next action potential and, thereby, may increase the action potential frequency in mPVSMCs.
TMEM16A has at least 4 alternatively spliced segments (named as a, b, c, and d). Segment b includes a putative calmodulin binding domain and influences the Ca 2+ sensitivity of TMEM16A Cl − conductance, and segment c affects the voltage dependence (7, 8) . Thus, the TMEM16A transcript can produce multiple protein isoforms and may differentially contribute to CaCC activity in various types of cells. In mPVSMCs, the CaCC activity is generated by homo-and heterodimer formations of two TMEM16A splicing variants, TMEM16A(abc) and TMEM16A(acd) isoforms (4).
In the next series of experiments, the effect of actin disruption was examined in HEK293 cells (Health Science Research Resources Bank, Osaka) transiently expressing murine TMEM16A splicing variants (2 mg) using Lipofectamine 2000 reagent (Invitrogen). At 24 -72 h after transfection, TMEM16A-expressing HEK293 cells elicited CaCC currents, which had characteristics consistent with those of our previous measurements (4) . Neither the current density nor the kinetics (t act and t deact ) of CaCC currents were affected by the treatment with 1 mM cytochalasin D for 4 h in TMEM16A(abc)-and TMEM16A(acd)-HEK293 cells (n = 3 -6, P > 0.05; Fig. 2) .
Because the expression ratio of TMEM16A(abc) and TMEM16A(acd) isoforms was 64.5% and 25.8%, respectively, in mPVSMCs (4), HEK293 cells were transiently cotransfected with cDNAs of TMEM16(abc) and TMEM16A(acd) at the ratio of 2:1 (a mixture of 1.33 and 0.67 mg, respectively). Addition of cytochalasin D failed to alter any parameters of CaCC currents (current amplitude, t act , and t deact ) in TMEM16A(abc) / (acd)-coexpressing HEK293 cells (n = 4, P > 0.05; Fig. 2 ). These results strongly suggest that the effect of cytochalasin D in mPVSMCs on the deactivation kinetics is mediated by actin disruption but not direct action of cytochalasin D on the TMEM16A channel itself. The different effects of cytochalasin D between mPVSMCs and TMEM16A-expressing HEK293 cells may be due to a difference in the expression level of actin filaments. Because VSMCs have a well-developed actin cytoskeleton compared with non-muscle cells (9) , such as HEK293 cells, the effect of actin disruption on the activity of CaCC current in mPVSMCs is supposed to be stronger than that in HEK293 cells. It is particularly noteworthy that the t deact values of CaCC in mPVSMCs after the treatment with cytochalasin D became significantly larger and close to those in TMEM16A-expressing HEK293 cells (compare Figs. 1E and 2D) .
It has been reported that actin disruption by the application of 10 mM cytochalasin D causes a decrease of ionomycin-activated CaCC conductance in HEK293 cells transfected with murine TMEM16A (8) . In this study, the treatment with 1 mM cytochalasin D did not affect the current amplitude of CaCC in mPVSMCs and HEK293 cells expressing TMEM16A splice variants. Only the deactivation kinetics of CaCC in mPVSMCs was modulated by cytochalasin D. Although the reason for the discrepancy remains to be resolved, it may be due to differences in the concentrations of cytochalasin D and the expression levels of TMEM16A proteins between two studies.
So far, the direct interaction of actin filaments with the N-terminus of the ClC-2 Cl − channel and the C-termini of epithelial Na + channel and large-conductance Ca 2+ -activated K + (BK Ca ) channel has been identified (10 -12). The membrane expression of cystic fibrosis transmembrane conductance regulator (CFTR) Cl − channel is decreased by actin disruption (13) . Actin disruption attenuates CFTR Cl − current and activates BK Ca current and ClC-2 current (10, 13, 14) . In addition, dynamic mobilization of BK Ca channel is restricted by actin filaments (5) . In this study, we found that the activity of TMEM16A channel is also modified by the actin cytoskeleton. It has been reported that TMEM16A channel interacts with the scaffold proteins ezrin, radixin, and moesin (15) . The ezrin-radixin-moesin complex can organize the cytoskeleton by linking of actin filaments to the plasma membrane, suggesting that TMEM16A channel is associated with the actin cytoskeleton.
The identification of the domain responsible for interaction with actin filament is a critical issue for understanding the regulatory mechanism of ion channel activities. A conserved sequence motif, L/I-X-D/E-X-X-L/I, establishes as a putative actin-binding domain (12) . The sequence data of murine TMEM16A (GenBank accession number NM_178642) revealed that the open reading frame contained two actin-binding domain candidates, 192 LLEAGL at the N-terminus and 786 IIEIRL at the third intracellular loop (between S6 and S7 transmembrane domains) of TMEM16A channel. Further experiments are necessary for clarifying the involvement of these binding motifs in the regulation of CaCC activity by actin cytoskeleton in mPVSMCs.
The portal vein shows spontaneous contraction that substantially contributes to the blood flow from mesenteric vascular beds to the liver. Because the TMEM16A channel is abundantly expressed in mPVSMCs and contributes to CaCC activity, identification of the regulatory factors of the TMEM16A channel is essential for understanding the mechanisms underlying the physiological and pathophysiological regulations of gastroliver circulation. Moreover, the expression level of actin filament and its polymerization states, which are possibly altered by SMC phenotypes, the contractile and proliferative phenotypes, may be a pivotal factor to determine the CaCC activity through TMEM16A channels. In conclusion, the activity of TMEM16A-encoded CaCC is partly modified by actin cytoskeleton in VSMCs.
